pre-miRNA Information | |
---|---|
pre-miRNA | mmu-mir-1906-1 |
Genomic Coordinates | chr12: 109544541 - 109544620 |
Description | Mus musculus miR-1906-1 stem-loop |
Comment | None |
RNA Secondary Structure | |
pre-miRNA | mmu-mir-1906-2 |
Genomic Coordinates | chrX: 88759474 - 88759553 |
Synonyms | mmu-mir-1906, Mir1906 |
Description | Mus musculus miR-1906-2 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |
---|---|
Mature miRNA | mmu-miR-1906 |
Sequence | 48| UGCAGCAGCCUGAGGCAGGGCU |69 |
Evidence | Experimental |
Experiments | Microarray |
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | Tln2 | ||||||||||||||||||||
Synonyms | 5730421P04Rik, AI507121, AI787438, AL118320, mKIAA0320 | ||||||||||||||||||||
Description | talin 2 | ||||||||||||||||||||
Transcript | NM_001081242 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on Tln2 | |||||||||||||||||||||
3'UTR of Tln2 (miRNA target sites are highlighted) |
>Tln2|NM_001081242|3'UTR 1 GACACCCCCCATGCTGGTGAGCCCCAGGAGGTGGTTCCTACTCCCCCAACAAGAACTGGACATACTGGTGTCCCCCAGAG 81 CCAGGAACTTCCTGGAAACTGCTGGCCCTCCACCGGAGTCTGTCTCTCTCAGTCCTCAGTCCCGTCACTATCAGCTGCAT 161 GATCATGGTCTCACACGGTACAGTGTCCCACCCACAGCTCTTCCAGCTCCCCTCACGCCTCGCTATATCTCAGGACAGAG 241 GGCGCATTTCATGGACTGTTACCAAAAAAGAAAAGTCAGTATTACGTTGTTCTCAGACACCTGTACTCCGTGTCCTCTAA 321 GACTGCTCCAGGGCCTCTTTGTGAAATCACACTCGGGAAAGAACAATGCTAATAACGGCTCACAGGAATCATCAGTATCA 401 TGGACATAGAGATTCTCTCTCTGGAGAGAAGACAGCTGGAGTTGGACACTGTTAATAAAGCCAGAAACACTCCCAAGTGA 481 ACTCTGGAGTCACAGAGGTCTGTGTAAGTGTGGGGCACTGACTCACCCACGGGGGAGAAGATCCCCTACCCGTTTGCACG 561 CTTTTCTCGCCTCAGTGTGTAAGCTCCTTGTACAACTACACCCATCTTGTATTCTGTGGCCCAGAAAAATGGAAGTTATT 641 TTTTTTTCCCCCTTCCATAATCCAAAGGGCAGAGTTGTGGAAAGTGGTCAGGGTTAGGTGGGTAGGGGCCGGAATAAAAT 721 ACTGGGCTCCTCACTCAGCAAAGCTGTTTCAGTTTATGCAGACACACACATGGAGACTATGTCCCTGATGGATCTCAGTG 801 CAGCGCCCCCTGGAGGAAGAGTCAGGTAGCATTTAGGAAGGAGGTTCCCATGTTCGAGCCCTATTATCAGTTTCTGTGCA 881 CTTGAGAGGGTCCAAGTTCAAGAAGGAAAGTTATTTGTTTAGAACTTTGACCTTTGATCTCAAGGGGGCATTTCCCACCA 961 TTTATCTTAATAATCCTAAAATCTAAATGTCCCCTCTGGTCATTGTGAACCTGTGTGACAGCATTGCTTGTTGTCACAGA 1041 AGTGTTTTCACAGTACATCATCTGGGTGCTGCCCTTTCAACCTCCCGATGCCTTCCCCTCGTGCCTTTCCTCTCAGGGCC 1121 CTCTTCTGGAGAGAACATCAGAGATCCCTGACTTTACATTTGAGTTGAGCCCCTGCCTAAGATGAGGGATGAGGGAGGGC 1201 CTGATACCAAGTACCAGCATGTTAATGAACTCGTGAAGAGTTAGCAGGGGCTTGCTTAGACTGTAGCTCAGTTGGTAGAG 1281 TGTTTGCCTGGTTAGCATGCACAAAGCCCTGGGTCCCATCACATAAACTCGATGTGGTGCCACAAGCCTGTAATCCCAGC 1361 ACCAGGGAGATAGAGGCAGGTGGATCAGAAGTTCAAGGTTATCTTTGGCTACATAGTAAGTCAGAGACCAGCCTTGGCTA 1441 CATAGTAAATTATAGAGAAAAGCCTTGGCTACATGAGACCCTGCCTCCAAAAGAGGAGAGAGAAGGAAAAAAGGCATATG 1521 GTCTTCAAGGCTAATGGCTGCTGAGGGCAGACTTTCTCCCCCTTAATGATATGATACCAGTACCACATTGTATGTTGGGC 1601 TCACCACTTCCATCCAGATTTCTACCAAAGAAGAAACACTGGTACTCTGGTCCTCCGAAAGGAAAGAGAGAATCAACCCT 1681 CGACCTTGCCAGATGAGGCTCCTCGAGCAGACTCTCCTGTGCCACAGCTCTAAAACATAATGAAATCCTGACACCTTCCC 1761 AGATGTGTAGAGACTTACACATGCTGCACAAAGGAATCCCTTTCACACAGGTAGAAGGATCTAAGTACGGTGTGAATGAA 1841 AAGCAAATGCAGGGCACACATGGAAGGACTGAGGCTGAGCAGGGCTGCTGGAGAGCCTCCATGCTGGGAGCCCTTGATGC 1921 TCATGGGAAAGCAAACCGCCTCGCTCACCCTTGTTGAGTGTAACTCTTTTTGTTTGTTTTGTTTTTCCCAGACAGGGTTT 2001 CTCTGTATAGCCCTGGCTGTCCTGGAACTCACTCTGTAGACCAGGCTGGCCTCGAACTCAGAAATCTGCCTGCCTCTGCC 2081 TCCCAAGCGCTGGGATTAAAGGTGTGCGCCACTTCACGCCTTTGCTGGGTACTATGCAAAACTATTAAGCCAAACCCCAA 2161 AGTTCATGATCAAGACGGTGATCTCACACAGTAGGACAAGAGGCTCTCCTGCAGCTGGCTCACCCTCTTCCTGTAGGATA 2241 TGCTTCCAGGCAGCTAGCCCCTCACCCCTCCTCCTACCTGTCCCCTGCCACATTGGACATTCCAGGGGCAGGACAGATAC 2321 CAAGTGTCTGTCCCTACCCCAGGGTGGTTTAAAACTTTCACAGAAGTGGACACAGGAGAAGACCTCTAACAAATGAAGGC 2401 AAGGGGCCATGAGGGGAGTTTCAGGACAGTGGGACAGTGTCCTCCTGTCTGGGGTGATGTGCACTAGGAACTTGGGAAGA 2481 GGTCGTTCTCAGGTCTCTCCTCCATGGTCGTGGGCCTACTTCGCACCTGTCCCTTGCTAGCCCATGCTGTGTCCATGTAT 2561 GTGAATGTCCTCGTGGCTGGCTGATCTCTCCTCATTTCATAAACCAGCGGAAATGCTGGGCTACAGGCATTACTTAATGC 2641 TGCTGCTTGTGTCCCCAGAGGCACTGAGGGGTCTTCTGGCTCCTAAGGGAGAAAGAATGCAGATGTAGTGAATTGCAGTT 2721 TGGAGTAGTTTCAAGGCCCATGGCCCAAGGCCTGGAACATGGAATTCATCTGTGAGGGGGACTGGGAATGCAGCAGAGTG 2801 CACTCCTACCTCTGGTCCCGTGAGGGAGGCCAACATTGGGTGTTGAATCCTTACACTGATCTTCCTGTCCTGTGTTTCCC 2881 TGTTTGATGGTTAAAAGTAGGATGTGCCTGATGGCTGGGAAATTGCATTTGGTTTACTTCTGCCTTTCAGAGGTCTTTTG 2961 GTTTTCAGGATGCAAAAGCCATGTTTGGTCAGACAGCCCTGGGTAGCCCTTCCACTGGCCAGTTTGGGAGGTGGTCTTGA 3041 AGGTCATCATAAGCTGATACTTAGGACCTAGGCAGTCCTCCAGTTGGCGTTGGTGATTTCCAGAGGCAGCTGCCCTGGCT 3121 TCAGTTTGTGCACGGGCTTTCAGGGCTAAGCCACCACAGATCTGCTGGCGCACACTCTTCGTCCAGAAAACCCTCTAAGC 3201 CTCTTAGCACACACATCTGCTTGTTGTCTGAGTTCTCTTCCGGCTGGTGAGAGTAGGGACAGCTGAAACCAAGTGTTAAA 3281 AACCGTGTAACGAGGTGTGACGGCGAACATTTAGAATCCCAGCACTGGGGAGGTGGAGGCAGGAGAATTGCCAAGTCTAA 3361 GGTCAGCCTGGGCTGGGTAACAAGATCCTGTCTCAGAAAACCAACAGCTAATGGAAGTAACTTAGTGTTAAAATGTTTGC 3441 CTCGTAAGTGCTAGGCCCTGGGTTGGTTCCCAGCAACACACAGACTTTAACCAAAATGTCCCACCACCTAAAAGCATGTA 3521 TTTATCCCCACCTCCTAAGCGGCCCCAGAACCAGAACCTGATGAAGGAATTAGGGTGGAGGTGGTAAGAGGTGCCACTGC 3601 ACTTCCTCTTGTCTCTCTGGCAGGTGGTCCCCCAAATCTCCCCGAGCTTTGCAGTCCAGGGCTAAGGTAGAGCCTCTGGG 3681 AGCTAAAGCTTAAGATCTCAGCACTGATTGTATGCTCTGCTCAGACACCTAGAAGAAACGAACTCGGTGACCGCGCACAC 3761 AGACAGACACATCTGAGTTACTGAGCAAGTTGCAAGGAACTGGAAGAAAATAGTTGCTTACAGGCTGAGAGGCAACAGTG 3841 CTCAGAGTCCTAAAAGCCAAAGAAAGGTCTTAGGGGCTATGCTGGTGGCCCAGATCTCACCTCACCCCAGAGTCCCTCCC 3921 ACTGAGTCGGCAGCCTCCGCTAGGAAAGACATCCTCCACAAATCGCCTGACGTCACTGCTCCATCAGGGTGAGCTTGCAC 4001 TTGATGTATTAAGTTGTGGTCATTTGGAATGAGCACGAGGAGGGAACTTCCAGTAGTCTCACAATACTATGAAGAAGGGC 4081 TGACACTTTTCTGTGAAACAGGCTAGGTTTTATCTGGTCTCCCTGGAACCCAGCTCACTGCCCACCAGGAGGCAATAGCA 4161 TGCGAGCCCCTCTGCAGCCACATCTGTCAGGAGACAAGAAAGGGAAGCTCTGCCCTTGTCATAATGTTTAATCACATAAA 4241 TTAATTTATCTAATCACATAAATTATTTTTTTTATTCATCAGAAATAAACTTTTAAAGGAATGAAAAAAAAAAAAAAAAA 4321 A Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | C2C12 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1385343. RNA binding protein: 聽AGO2. Condition:C2C12_DM_Ago2_CLIP-Seq_myotubes
... - Zhang X; Zuo X; Yang B; Li Z; Xue Y; Zhou et al., 2014, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Zhang X; Zuo X; Yang B; Li Z; Xue Y; Zhou et al. - Cell, 2014
MicroRNAs are well known to mediate translational repression and mRNA degradation in the cytoplasm. Various microRNAs have also been detected in membrane-compartmentalized organelles, but the functional significance has remained elusive. Here, we report that miR-1, a microRNA specifically induced during myogenesis, efficiently enters the mitochondria where it unexpectedly stimulates, rather than represses, the translation of specific mitochondrial genome-encoded transcripts. We show that this positive effect requires specific miR:mRNA base-pairing and Ago2, but not its functional partner GW182, which is excluded from the mitochondria. We provide evidence for the direct action of Ago2 in mitochondrial translation by crosslinking immunoprecipitation coupled with deep sequencing (CLIP-seq), functional rescue with mitochondria-targeted Ago2, and selective inhibition of the microRNA machinery in the cytoplasm. These findings unveil a positive function of microRNA in mitochondrial translation and suggest a highly coordinated myogenic program via miR-1-mediated translational stimulation in the mitochondria and repression in the cytoplasm.
LinkOut: [PMID: 25083871]
|
CLIP-seq Support 1 for dataset GSM1385343 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | C2C12 / C2C12_DM_Ago2_CLIP-Seq_myotubes |
Location of target site | NM_001081242 | 3UTR | GUGUAGAGACUUACACAUGCUGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 25083871 / GSE57596 |
CLIP-seq Viewer | Link |
27 mmu-miR-1906 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT578439 | Irgq | immunity-related GTPase family, Q | 2 | 10 | ||||||||
MIRT578971 | Dhdh | dihydrodiol dehydrogenase (dimeric) | 2 | 4 | ||||||||
MIRT580446 | Tln2 | talin 2 | 2 | 2 | ||||||||
MIRT582494 | Mbtps2 | membrane-bound transcription factor peptidase, site 2 | 2 | 2 | ||||||||
MIRT587588 | Cox15 | cytochrome c oxidase assembly protein 15 | 2 | 2 | ||||||||
MIRT589524 | Mtf1 | metal response element binding transcription factor 1 | 2 | 2 | ||||||||
MIRT591281 | Klc1 | kinesin light chain 1 | 2 | 4 | ||||||||
MIRT591935 | Ddx19b | DEAD (Asp-Glu-Ala-Asp) box polypeptide 19b | 2 | 2 | ||||||||
MIRT592084 | Sorcs2 | sortilin-related VPS10 domain containing receptor 2 | 2 | 2 | ||||||||
MIRT592206 | Mapkap1 | mitogen-activated protein kinase associated protein 1 | 2 | 4 | ||||||||
MIRT592349 | Armcx6 | armadillo repeat containing, X-linked 6 | 2 | 4 | ||||||||
MIRT592351 | Angel1 | angel homolog 1 | 2 | 2 | ||||||||
MIRT592365 | 4930444A02Rik | protein-O-mannose kinase | 2 | 2 | ||||||||
MIRT592427 | Spsb4 | splA/ryanodine receptor domain and SOCS box containing 4 | 2 | 2 | ||||||||
MIRT592671 | Itgav | integrin alpha V | 2 | 2 | ||||||||
MIRT592712 | Fbxo21 | F-box protein 21 | 2 | 4 | ||||||||
MIRT593155 | Itsn1 | intersectin 1 (SH3 domain protein 1A) | 2 | 2 | ||||||||
MIRT593662 | Spen | SPEN homolog, transcriptional regulator (Drosophila) | 2 | 2 | ||||||||
MIRT593976 | Cdc14b | CDC14 cell division cycle 14B | 2 | 2 | ||||||||
MIRT597931 | Pacsin2 | protein kinase C and casein kinase substrate in neurons 2 | 2 | 2 | ||||||||
MIRT597949 | Opa1 | OPA1, mitochondrial dynamin like GTPase | 2 | 2 | ||||||||
MIRT598550 | Isoc1 | isochorismatase domain containing 1 | 2 | 2 | ||||||||
MIRT599017 | Fgd4 | FYVE, RhoGEF and PH domain containing 4 | 2 | 2 | ||||||||
MIRT600307 | Tacc1 | transforming, acidic coiled-coil containing protein 1 | 2 | 2 | ||||||||
MIRT603647 | Otop1 | otopetrin 1 | 2 | 2 | ||||||||
MIRT605000 | Fam168b | family with sequence similarity 168, member B | 2 | 2 | ||||||||
MIRT606275 | Oxsm | 3-oxoacyl-ACP synthase, mitochondrial | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|